PROCTER & GAMBLE HEALTH
Back to Cashflow Statement
|
PROCTER & GAMBLE HEALTH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Jun2023 | Jun2022 | Jun2021 | Jun2020 | Dec2018 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-98 Cr | ₹-289 Cr | ₹-387 Cr | ₹-883 Cr | ₹-30 Cr |
What is the latest Cash Flow from Financing Activities ratio of PROCTER & GAMBLE HEALTH ?
Year | Cash Flow from Financing Activities |
---|---|
Jun2023 | ₹-98 Cr |
Jun2022 | ₹-289 Cr |
Jun2021 | ₹-387 Cr |
Jun2020 | ₹-883 Cr |
Dec2018 | ₹-30 Cr |
How is Cash Flow from Financing Activities of PROCTER & GAMBLE HEALTH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Jun2023 | ₹-98 Cr | Negative | |
Jun2022 | ₹-289 Cr | Negative | |
Jun2021 | ₹-387 Cr | Negative | |
Jun2020 | ₹-883 Cr | Negative | |
Dec2018 | ₹-30 Cr | - |
Compare Cash Flow from Financing Activities of peers of PROCTER & GAMBLE HEALTH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PROCTER & GAMBLE HEALTH | ₹7,977.0 Cr | -0.2% | 1.5% | -5.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PROCTER & GAMBLE HEALTH | -0.2% |
1.5% |
-5.3% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses